OSAM
HRMY icon

O'Shaughnessy Asset Management’s Harmony Biosciences HRMY Stock Holding History

O'Shaughnessy Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Buy
10,212
+2,301
+29% +$72.6K ﹤0.01% 1734
2026
Q1 		$222K Buy
+7,911
New +$259K ﹤0.01% 1939
2025
Q2 		– Sell
-20,073
Closed -$666K – 2441
2025
Q1 		$666K Sell
20,073
-377
-2% -$13.5K 0.01% 1180
2024
Q4 		$704K Buy
20,450
+420
+2% +$14.4K 0.01% 1130
2024
Q3 		$711K Buy
20,030
+791
+4% +$27.8K 0.01% 1059
2024
Q2 		$580K Buy
+19,239
New +$579K 0.01% 1066

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

O'Shaughnessy Asset Management's HRMY Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Harmony Biosciences (HRMY) stake by 29% in Q2 2026, buying an estimated $72.6K and bringing the position to 10,212 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

O'Shaughnessy Asset Management first reported a position in HRMY in Q2 2024 and has held it in 6 quarters since. The position peaked at $711K in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • O'Shaughnessy Asset Management held 10,212 shares of Harmony Biosciences worth $372K as of Q2 2026.
  • O'Shaughnessy Asset Management bought 2,301 Harmony Biosciences shares in Q2 2026, an estimated $72.6K.
  • Harmony Biosciences made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1734 holding.
  • O'Shaughnessy Asset Management first reported a position in Harmony Biosciences in Q2 2024 and has held it in 6 quarters since.
  • O'Shaughnessy Asset Management's Harmony Biosciences position peaked at $711K in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.